Scalper1 News
NantKwest (NK) raised $207 million in an upsized IPO Monday evening, pricing 8.3 million shares at 25 and boosting the hot biotech sector. It had planned to raise $151 million by offering 7 million shares at a price range of 20 to 23. NantKwest is one of eight IPOs planned for the week of July 27 that look to raise about $2 billion. NantKwest is developing therapies for the treatment of cancer, in the hot field of immunotherapy that includes Scalper1 News
Scalper1 News